MedPath

Different Injection Site Maps & Intravesical Botulinum Toxin

Not Applicable
Not yet recruiting
Conditions
Bladder Disease
Registration Number
NCT06185218
Lead Sponsor
Başakşehir Çam & Sakura City Hospital
Brief Summary

Botulinum toxin injection into the bladder is used in current practice in urological diseases such as overactive bladder or interstitial cystitis. As far as is known, botulinum toxin injection sites have not been clearly defined. In this study, investigators are planning to compare botulinum toxin effectiveness with different injection site maps.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Older than 18 years
  • Interstitial cystitis patients
  • Overactive bladder
Exclusion Criteria
  • younger than 18 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Overactive bladder-V8 questionnaire will be used for efficacy of treatment.Estimated 1 month for every patient after treatment.

The questionnaire contains 8 questions and every question may be scored between 0 and 5. Additionally, male gender get 2 points more. Therefore, a patient may be get between 0 and 42 points. More score means worse complaint.

Urodynamics test will be assessed for efficacy of treatment.Estimated 1 month for every patient after treatment.

Possible bladder contractions and residual volume will be measured in urodynamic testing to demonstrate effectiveness after treatment. The lack of pathological bladder contractions and normal residual urine mean better for patient and, show improving.

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.